Mutual Fund Ownership
Ownership as on: Thu, 19 Sep, 2024

Quant Large Cap Fund Regular Growth

NA
Equity
Amount Invested (Cr.)120.69
% of AUM5.54%

Quant Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)22.00
% of AUM5.10%

Tata India Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)53.16
% of AUM4.49%

LIC MF Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)2.94
% of AUM4.10%

ITI Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)7.30
% of AUM3.75%

FAQs about Zydus Lifesciences share price

Zydus Lifesciences is trading at 1058.10 as on Thu Sep 19 2024 09:59:57. This is -1.97% lower as compared to its previous closing price of 1079.35.

The market capitalization of Zydus Lifesciences is 106469.62 Cr as on Thu Sep 19 2024 09:59:57.

The 52 wk high for Zydus Lifesciences is 1323.90 whereas the 52 wk low is 567.85

Zydus Lifesciences can be analyzed on the following key metrics -

  • TTM P/E: 26.00
  • Sector P/E: 31.32
  • Dividend Yield: 0.28%
  • D/E ratio: -

Zydus Lifesciences reported a net profit of 3859.50 Cr in 2024.

Recommended For You
Trending Stocks
424.10+10.25(2.48%)
1,874.90+35.85(1.95%)
3,793.00+69.35(1.86%)
3,685.65-44.00 (-1.18%)
HomeMarketsPremiumInstant LoanMint Shorts